GPhA applauds FDA's action to address shortage of Doxil, methotrexate

February 21, 2012
The Food and Drug Administration's action to address the ongoing shortage of certain cancer drugs has garnered praise from a group representing the manufacturers and distributors of generic pharmaceuticals.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Or, Create an Account >>
Related Terms:
Generics
Pharmacist Society
Collaborative Care
Health & Wellness
Latest News
Regulatory and Washington
Pharmacy
pharmaceuticals
Doxil
Food and Drug Administration
HTML
HTML element
Methotrexate
© 2012 Drug Store News. All Rights Reserved.